Management of patients with acute hyperkalemia.
作者信息
Elliott Meghan J, Ronksley Paul E, Clase Catherine M, Ahmed Sofia B, Hemmelgarn Brenda R
机构信息
Department of Medicine, McMaster University, Hamilton, Ont., Canada.
出版信息
CMAJ. 2010 Oct 19;182(15):1631-5. doi: 10.1503/cmaj.100461. Epub 2010 Sep 20.
Abstract
摘要
相似文献
1
Management of patients with acute hyperkalemia.急性高钾血症患者的管理
CMAJ. 2010 Oct 19;182(15):1631-5. doi: 10.1503/cmaj.100461. Epub 2010 Sep 20.
2
Treatment of hyperkalemia in patients with chronic kidney disease--a focus on medications.慢性肾脏病患者高钾血症的治疗——聚焦于药物治疗
CANNT J. 2010 Jul-Sep;20(3):49-53; quiz 54-5.
3
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.在慢性肾脏病中使用皮下特布他林以降低血钾浓度。
Am J Kidney Dis. 2005 Jun;45(6):1040-5. doi: 10.1053/j.ajkd.2005.02.016.
4
A Brief Review of the Pharmacology of Hyperkalemia: Causes and Treatment.高钾血症的药理学简述：病因与治疗
South Med J. 2019 Apr;112(4):228-233. doi: 10.14423/SMJ.0000000000000957.
5
Extreme hyperkalemia.严重高钾血症。
South Med J. 2006 Jan;99(1):96. doi: 10.1097/01.smj.0000197120.22152.ae.
6
Therapeutic approach to hyperkalemia.高钾血症的治疗方法。
Nephron. 2002;92 Suppl 1:33-40. doi: 10.1159/000065375.
7
Timing of administration of beta-agonists.β受体激动剂的给药时间。
Mayo Clin Proc. 2008 Mar;83(3):368; author reply 368. doi: 10.4065/83.3.368.
8
Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.碳酸氢盐给药对透析患者血浆钾的影响：与胰岛素和沙丁胺醇的相互作用。
Am J Kidney Dis. 1996 Oct;28(4):508-14. doi: 10.1016/s0272-6386(96)90460-6.
9
Management of hyperkalemia in dialysis patients.透析患者高钾血症的管理。
Semin Dial. 2007 Sep-Oct;20(5):431-9. doi: 10.1111/j.1525-139X.2007.00312.x.
10
Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients.碳酸氢盐与β₂肾上腺素能激动剂（沙丁胺醇）联合方案用于慢性肾衰竭患者高钾血症的急性治疗
J Korean Med Sci. 1997 Apr;12(2):111-6. doi: 10.3346/jkms.1997.12.2.111.
引用本文的文献
1
The burden of hyperkalaemia in chronic kidney disease: a systematic literature review.慢性肾脏病中高钾血症的负担：一项系统文献综述
Clin Kidney J. 2025 Apr 29;18(5):sfaf127. doi: 10.1093/ckj/sfaf127. eCollection 2025 May.
2
Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection Fraction.射血分数降低的心力衰竭患者队列中高钾血症的医疗成本和经济影响
J Clin Med. 2024 Dec 26;14(1):58. doi: 10.3390/jcm14010058.
3
The impact of serum potassium ion variability on 28-day mortality in ICU patients.血清钾离子变异性对 ICU 患者 28 天死亡率的影响。
PLoS One. 2024 Nov 4;19(11):e0310046. doi: 10.1371/journal.pone.0310046. eCollection 2024.
4
Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function.肾功能减退患者静脉注射胰岛素治疗高钾血症
J Clin Med. 2024 Aug 28;13(17):5103. doi: 10.3390/jcm13175103.
5
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study.帕替罗默作为需要紧急血钾管理的患者的辅助治疗药物的效用（PLATINUM）：一项多中心、随机、双盲、安慰剂对照、平行组研究的设计。
BMJ Open. 2023 Jun 12;13(6):e071311. doi: 10.1136/bmjopen-2022-071311.
6
Development and validation of a dynamic deep learning algorithm using electrocardiogram to predict dyskalaemias in patients with multiple visits.一种利用心电图预测多次就诊患者电解质紊乱的动态深度学习算法的开发与验证
Eur Heart J Digit Health. 2022 Nov 22;4(1):22-32. doi: 10.1093/ehjdh/ztac072. eCollection 2023 Jan.
7
Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis.帕替罗姆和环硅酸锆钠治疗高钾血症：一项系统评价和荟萃分析
Curr Ther Res Clin Exp. 2021 Jul 5;95:100635. doi: 10.1016/j.curtheres.2021.100635. eCollection 2021.
8
Adverse Gastrointestinal Effects with Kayexalate or Kalimate: A Comprehensive Review.使用聚苯乙烯磺酸钠或降钾树脂的不良胃肠道影响：一项全面综述。
Clin Exp Gastroenterol. 2021 Jan 11;14:1-18. doi: 10.2147/CEG.S278812. eCollection 2021.
9
Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.急诊科急性高钾血症：来自改善全球肾脏病预后组织会议的总结
Eur J Emerg Med. 2020 Oct;27(5):329-337. doi: 10.1097/MEJ.0000000000000691.
10
The burden of hyperkalemia in Germany - a real world evidence study assessing the treatment and costs of hyperkalemia.德国高钾血症负担——一项真实世界证据研究评估高钾血症的治疗和成本。
BMC Nephrol. 2020 Aug 8;21(1):332. doi: 10.1186/s12882-020-01942-2.
本文引用的文献
1
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.《系统评价与Meta分析优先报告条目声明》：针对评估卫生保健干预措施的研究的报告规范解释与阐述
Ann Intern Med. 2009 Aug 18;151(4):W65-94. doi: 10.7326/0003-4819-151-4-200908180-00136. Epub 2009 Jul 20.
2
Management of severe hyperkalemia.严重高钾血症的管理
Crit Care Med. 2008 Dec;36(12):3246-51. doi: 10.1097/CCM.0b013e31818f222b.
3
Effects of presentation and electrocardiogram on time to treatment of hyperkalemia.临床表现和心电图对高钾血症治疗时间的影响。
Acad Emerg Med. 2008 Mar;15(3):239-49. doi: 10.1111/j.1553-2712.2008.00058.x.
4
Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.醋酸氟氢可的松对降低接受血液透析的终末期肾病患者血清钾水平的作用。
Nephrol Dial Transplant. 2007 Nov;22(11):3273-6. doi: 10.1093/ndt/gfm386. Epub 2007 Jul 5.
5
Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.住院患者高钾血症快速发展的相关危险因素。
Drug Saf. 2007;30(1):71-80. doi: 10.2165/00002018-200730010-00007.
6
A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.氟氢可的松治疗血液透析患者高钾血症的随机对照试验。
Am J Kidney Dis. 2006 May;47(5):809-14. doi: 10.1053/j.ajkd.2006.01.014.
7
Potassium disorders--clinical spectrum and emergency management.钾紊乱——临床谱与急诊处理
Resuscitation. 2006 Jul;70(1):10-25. doi: 10.1016/j.resuscitation.2005.11.002. Epub 2006 Apr 4.
8
2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.2005年美国心脏协会心肺复苏及心血管急救指南。
Circulation. 2005 Dec 13;112(24 Suppl):IV1-203. doi: 10.1161/CIRCULATIONAHA.105.166550. Epub 2005 Nov 28.
9
The efficiency of potassium removal during bicarbonate hemodialysis.碳酸氢盐血液透析过程中钾清除的效率。
Hemodial Int. 2005 Jul;9(3):296-302. doi: 10.1111/j.1492-7535.2005.01144.x.
10
Emergency interventions for hyperkalaemia.高钾血症的紧急干预措施。
Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD003235. doi: 10.1002/14651858.CD003235.pub2.
Zotero 插件